Sitagliptin Metformin XR Spirig HC 50/500 mg
Sitagliptin Metformin XR Spirig HC 50/500 mg is a medicine authorised by Swissmedic under authorisation number 69160. The authorisation holder is Spirig HealthCare AG. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 03 August 2023 and the authorisation is limited until 02 August 2028. ATC code A10BD07 places the medicine in the group Drugs used in diabetes.
| Authorisation number | 69160 |
|---|---|
| Name | Sitagliptin Metformin XR Spirig HC 50/500 mg |
| Full name | Sitagliptin Metformin XR Spirig HC 50/500 mg, Tabletten mit veränderter Wirkstofffreisetzung |
| Authorisation holder | Spirig HealthCare AG |
| Medicinal product code | Synthetic medicines |
| Dispensing category | B · Prescription only |
| ATC code | A10BD07 |
| First authorisation | 03 August 2023 |
| Authorisation validity | 02 August 2028 |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Sitagliptin Metformin XR Spirig HC 50/500 mg, Tabletten mit veränderter Wirkstofffreisetzung | B | 03 August 2023 |
| 2 | Sitagliptin Metformin XR Spirig HC 50/1000 mg, Tabletten mit veränderter Wirkstofffreisetzung | B | 03 August 2023 |
| 3 | Sitagliptin Metformin XR Spirig HC 100/1000 mg, Tabletten mit veränderter Wirkstofffreisetzung | B | 03 August 2023 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 60 | Tablette(n) | A10BD07 | 07.06.2. | B |
| 2 | 160 | Tablette(n) | A10BD07 | 07.06.2. | B |
| 3 | 60 | Tablette(n) | A10BD07 | 07.06.2. | B |
| 4 | 160 | Tablette(n) | A10BD07 | 07.06.2. | B |
| 5 | 30 | Tablette(n) | A10BD07 | 07.06.2. | B |
| 6 | 90 | Tablette(n) | A10BD07 | 07.06.2. | B |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Sitagliptin Metformin XR Spirig HC 50/500 mg authorised in Switzerland?
Yes. Sitagliptin Metformin XR Spirig HC 50/500 mg is authorised by Swissmedic under authorisation number 69160, data as of 01 September 2026. The authorisation is limited until 02 August 2028.
Which dispensing category does Sitagliptin Metformin XR Spirig HC 50/500 mg have?
Sitagliptin Metformin XR Spirig HC 50/500 mg is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of Sitagliptin Metformin XR Spirig HC 50/500 mg?
The authorisation holder is Spirig HealthCare AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.